Zdravka Medarova

Zdravka Medarova, Ph.D., is a cancer biologist whose work bridges basic science and translational medicine. She is the Co-founder and Chief Scientific Officer of TransCode Therapeutics, a biotechnology company developing RNA-based therapies for cancer, and has also served as an Associate Professor of Radiology at Harvard Medical School and a researcher at Massachusetts General Hospital’s Martinos Center for Biomedical Imaging. Her research focuses on the use of non-coding RNAs, such as microRNAs and siRNAs, as therapeutic agents, as well as the development of platforms for targeted delivery to tumors. With a background in genetics and extensive experience in nanomedicine, she has contributed to advancing precision oncology by designing strategies that not only treat cancer but also allow researchers and clinicians to monitor therapeutic efficacy in real time.